Al B. Benson III, MD, FACP, FASCO

Authored Items

Comparing the Cost of Treatment with Octreotide Long-Acting Release versus Lanreotide in Patients with Metastatic Gastrointestinal Neuroendocrine Tumors

Rajeev Ayyagari, PhD, Maureen Neary, PhD, MS, Shang Li, MS, Ariel Rokito, BS, Hongbo Yang, PhD, Jipan Xie, MD, PhD, Al B. Benson III, MD, FACP, FASCO

November 2017 Vol 10, No 8 in Business, Original Research

Role of NCCN in Integrating Cancer Clinical Practice Guidelines into the Healthcare Debate

Al B. Benson III, MD, FACP, FASCO, Elizabeth Brown, MD

February 2008, Vol 1, No 1 in Business

Last modified: April 23, 2019

• 
• 
• 

• 
• 
• 

•